Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTENSE-TBM
NCT04145258Phase 3Recruiting
- Sponsor
- ANRS
- Start
- Feb 2021
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of rifampicin, linezolid, aspirin in tuberculous meningitis (TBM), sponsored by ANRS. Started Feb 2021; status: recruiting.
02
Drugs
rifampicinlinezolidaspirin
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT04145258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04145258.